Symmetry Technologies Inc. moves to lab test and develop its "Inducible Expression System for Biosynthetic Production of Testerone in Men" Houston, TX, Oct. 7, 2013 (GLOBE NEWSWIRE) -- Symmetry Technologies Inc. (SMMR). is pleased to announce that it has initiated contact with a US based BioScience research and testing facility in its...

Symmetry Technologies Inc. acquires the rights to a ground breaking technology that produces Biosynthetic Testosterone in men from A Houston PhD led Biomedical research firm. Technology estimated value up to 10 Billion Dollars. Houston,TX, Aug. 14, 2013 (GLOBE NEWSWIRE) -- Symmetry Technologies Inc. (OTC:SMMR)  is pleased to announce the acquisition  from a Houston, PhD led Biomedical research firm, all work...

Symmetry Technologies Inc. licenses a Human Rejuvenation Nutraceutical product from an FDA compliant laboratory. It will sell under the name "Resurgencell" in the yearly $200 billion USD Nutraceutical market Houston,Tx, Aug. 1, 2013 (GLOBE NEWSWIRE) -- Symmetry Technologies Inc. (OTC:SMMR) is pleased to announce that it has licensed a Human Rejuvenation Nutraceutical product for retail sale from a US...